Sage Therapeutics Investor Relations Material
Latest events
Q2 2024
Sage Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Sage Therapeutics Inc
Access all reports
Sage Therapeutics, Inc., operates as a biopharmaceutical company, which focuses on the development and commercialization of medicines to treat central nervous system disorders. Its products include, for example, SAGE-547 and SAGE-217.
Key slides for Sage Therapeutics Inc
Q2 2024
Sage Therapeutics Inc
Q2 2024
Sage Therapeutics Inc
Latest articles
Our Favorite Spin-off Stories Since 2000
Spin-off motives vary widely across different companies, but the underlying objective remains the same: enhancing long-term shareholder value.
17 Oct 2024
Walmart: Walton, Retailing, and Everyday Low Prices
Walmart was founded in 1962 by Sam Walton, and has grown to become the largest retailer in the world, employing more than 2.1 million people worldwide.
17 Oct 2024
Texas Instruments: From Calculators to Master Capital Allocators
Texas Instruments has undergone many transformations from its origins in oil exploration to become one of the world's largest semiconductor producers.
11 Oct 2024
Ticker symbol
SAGE
Country
🇺🇸 United States